Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 62175-272

12 FDA label images from Lannett Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 62175-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxybutynin 1)

Chemical Structure (Oxybutynin 1)
Chemical structure of oxybutynin hydrochloride, showing its molecular framework with functional groups and bonds.*
FDA Label Image

Figure 1 (Oxybutynin 2)

Figure 1 (Oxybutynin 2)
A line graph depicting mean plasma oxybutynin concentration (ng/mL) over 24 hours for two dosing regimens: oxybutynin chloride extended-release tablets and oxybutynin 5 mg taken three times daily (TID). The x-axis represents time in hours, and the y-axis shows plasma concentration in ng/mL, with error bars for variability.*
FDA Label Image

Figure 2 (Oxybutynin 3)

Figure 2 (Oxybutynin 3)
A line graph depicting the mean plasma concentration of R-Oxybutynin in ng/mL over time in hours, from 0 to 24 hours. The plot includes data points with error bars, showing concentration changes peaking around 5 hours and remaining relatively stable thereafter.*
FDA Label Image

Figure 2 (Oxybutynin 4)

Figure 2 (Oxybutynin 4)
A horizontal bar chart showing mean change and standard deviation in episodes per week from baseline, comparing Oxybutynin chloride extended-release tablets to placebo. The x-axis ranges from -40 to 40, with a marker at zero indicating no change.*
FDA Label Image

Figure 3 (Oxybutynin 5)

Figure 3 (Oxybutynin 5)
A horizontal bar chart displaying mean change with standard deviation in episodes per week from baseline for oxybutynin chloride extended-release tablets. The x-axis ranges approximately from -40 to 40, with a centered vertical line at zero, indicating the change scale.*
FDA Label Image

Figure 4 (Oxybutynin 6)

Figure 4 (Oxybutynin 6)
A line chart displaying the mean change (± standard deviation) in episodes per week from baseline for oxybutynin chloride extended-release tablets. The horizontal axis represents the mean change in episodes per week, ranging from -40 to 40. Two data points or ranges are shown for oxybutynin and the extended-release tablets, indicating their effect size.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets 5 mg 100ct Bl Cia72805f Rev. 1019 (Oxybutynin 7)

Oxybutynin Chloride Extended Release Tablets 5 mg 100ct Bl Cia72805f Rev. 1019 (Oxybutynin 7)
Oxybutynin Chloride Extended Release Tablets USP 5 mg label. The label states each tablet contains 5 mg oxybutynin chloride in an extended-release formulation. It includes storage instructions to keep at 25°C with excursions permitted between 15°-30°C, and to protect from moisture and humidity. The label indicates the product is distributed by Lannett Company, Inc. and contains 100 tablets per bottle.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets 5 mg 500ct Bl Cia72331g Rev. 1019 (Oxybutynin 8)

Oxybutynin Chloride Extended Release Tablets 5 mg 500ct Bl Cia72331g Rev. 1019 (Oxybutynin 8)
Oxybutynin Chloride Extended-Release Tablets USP label showing 5 mg strength. The label indicates the product is distributed by Lannett Company, Inc. It contains 500 tablets, with storage instructions at 25°C (77°F) and protection from moisture and humidity. Dosage is noted as once daily, with a reference to the package insert for detailed dosing information.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets 10 mg 100ct Bl Cia72806f Rev. 10/19 (Oxybutynin 9)

Oxybutynin Chloride Extended Release Tablets 10 mg 100ct Bl Cia72806f Rev. 10/19 (Oxybutynin 9)
Label for Oxybutynin Chloride Extended Release Tablets USP, 10 mg strength, oral extended-release tablets. The label states each tablet contains 10 mg oxybutynin chloride, with usual dosage once daily. It includes storage instructions at 25°C (77°F) and protection from moisture and humidity. The label also notes 100 tablets per container and is distributed by Lannett Company, Inc.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets 10 mg 500ct Bl Cia72332g Rev. 10/19 (Oxybutynin 10)

Oxybutynin Chloride Extended Release Tablets 10 mg 500ct Bl Cia72332g Rev. 10/19 (Oxybutynin 10)
Label for Oxybutynin Chloride Extended-Release Tablets USP 10 mg, oral extended-release tablets. The label states each tablet contains 10 mg oxybutynin chloride, with a usual dosage of once daily. The package contains 500 tablets and is distributed by Lannett Company, Inc. Storage instructions and barcode are also visible.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets 15 mg 100ct Bl Cia72807f Rev. 10/19 (Oxybutynin 11)

Oxybutynin Chloride Extended Release Tablets 15 mg 100ct Bl Cia72807f Rev. 10/19 (Oxybutynin 11)
Oxybutynin Chloride Extended-Release Tablets USP label, showing 15 mg strength. The label states each tablet contains 15 mg oxybutynin chloride in extended-release form and includes storage and dosage instructions. The package contains 100 tablets and is distributed by Lannett Company, Inc.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets 15 mg 500ct Bl Cia72333g Rev. 10/19 (Oxybutynin 12)

Oxybutynin Chloride Extended Release Tablets 15 mg 500ct Bl Cia72333g Rev. 10/19 (Oxybutynin 12)
Label for Oxybutynin Chloride Extended-Release Tablets USP, 15 mg strength in tablet form. The label indicates a package containing 500 tablets, distributed by Lannett Company, Inc., Philadelphia, PA. It includes storage instructions and dosage information, emphasizing the extended-release formulation and daily use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.